ASSET PURCHASE AGREEMENT BY AND BETWEEN KALA PHARMACEUTICALS, INC., ALCON PHARMACEUTICALS LTD. AND ALCON VISION, LLC May 21, 2022Asset Purchase Agreement • May 23rd, 2022 • Kala Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This ASSET PURCHASE AGREEMENT (the “Agreement”) is entered into as of May 21, 2022 by and between Kala Pharmaceuticals, Inc., a Delaware corporation (“Seller”), Alcon Pharmaceuticals Ltd, a Swiss limited company (“Alcon Swiss’) and Alcon Vision, LLC, a Delaware limited liability company (“Alcon Vision” and, together with Alcon Swiss, collectively, “Buyer”). Seller and Buyer are sometimes referred to herein individually as a “Party” and together as the “Parties.”
